Introduction: Parapneumonic effusions, as a complication of community-acquired pneumonia (CAP), usually have a good course, but they sometimes progress into complicated parapneumonic effusion (CPPE) and empyema, thus becoming a significant clinical problem. Aim: To review clinical and radiological features, as well as diagnostic and therapeutic options in parapneumonic effusions.
INTRODUCTION
whereas the mortality risk was 3.7 times higher if the effusions were unilateral. [2] Some of the excess mortality is a result of the mismanagement of the parapneumonic effusion. [1, 3] The evolution of a parapneumonic effusion can be divided into three stages that represent a continuous spectrum. [3, 4] There is an uncomplicated parapneumonic effusion (UPPE), which is sterile exudative pleural effusion, resolved following treatment with antibiotic alone. [1, 5] The minority become secondarily infected (complicated parapneumonic effusion) (CPPE), and sometimes require drainage for resolution. [5] CPPE occurs in 10% of all patients hospitalized with effusion. [6] Ongoing infection eventually leads to the accumulation of pus in the pleural space (empyema). Epidemiological studies describe an increasing incidence of this problem. [11] Empyema requires pleural drainage and may also require surgical treatment. [6] [7] [8] About 60% of empyemas are related to a primary pneumonic process, therefore risk factors for pleural infection are similar to those for pneumonia. [1, 9] Independent risk factors for the development of empyema include diabetes mellitus, alcohol and intravenous abuse, immunosuppression, gastroesophageal reflux disease, aspiration and poor oral hygiene. [5, 6, 10 ] After a variable time interval, the pleural infection enters an organizing, stage characterized by fibroblast proliferation and the development of solid fibrous peel. This inhibits lung re-expansion and usually necessitates surgical thoracotomy and decortication. [5, 10] The clinical picture of parapneumonic effusions, along with symptoms of the underlying disease, pneumonia, presents symptoms typical of pleural effusion. [12] Signs and symptoms of an effusion vary depending on the underlying disease, but dyspnea, cough and pleuritic chest pain are the most common. [13] The purpose of the diagnostic protocol is to determine characteristic pneumonia and pleural effusions because the characteristics of the pleural fluid were the most reliable diagnostic parameter for assessing the type of pleural effusion which determines the further treatment of the patient. [12] Diagnosis includes radiographic examination (standard radiography, computer tomography -CT ), ultrasound, determination of markers of inflammation, basic biochemical analysis, blood culture, bacteriological and cytological examinations of sputum, pleural thoracentesis (macroscopic, biochemical, cytological and bacteriological examinations) and when there are complications, video-assisted thoracoscopy (VATS) with biopsy, and bronchoscopy. [11, 12, 13] In 1998, Light set the foundations of the way of the treating parapneumonic effusion and empyema creating the classification of parapneumonic effusions with a treatment schema. [15] There is considerable variation in the course and aggressiveness of parapneumonic effusions; therefore an understanding of its progression is important. [6] Increased mortality, complicated parapneumonic effusion and empyema often necessitate prolonged treatment, longer hospital stay and interventions. Thus, the identification of these patients and prompt management is important.
MATERIAL AND METHODS
Out of 755 patients, 175 (23.18%), had parapneumonic effusion. Thoracentesis was performed in 94 (53.71%) patients, 50 patients wеre with uncomplicated parapneumonic effusions (UCPPE) and 44 with complicated parapneumonic effusions (CPPE). The patients were diagnosed and treated in the University Infectious Diseases Clinic, Faculty of Medicine, Skopje in the Department of Respiratory Diseases in the period from September 2011 to June 2015. Individuals were excluded from the study because of cancer and malignant effusion, transudative effusion, vacuities, pulmonary emboli (PE), tuberculosis and age less than 18 years.
The demographic characteristics, physical examination findings, laboratory and microbiological findings of all study participants were monitored regularly at the University Infectious Diseases Clinic. Initial lung X-rays were taken for all patients at the Institute of Radiology, Medical Faculty in Skopje. After admission, all the patients underwent an ultrasound of the pleura and the lung with a three-dimensional echo at the University Infectious Diseases Clinic for diagnosis of pleural effusions and also diagnostic thoracocentesis if the size of effusion was larger than 10 mm. After verification of pneumonia and pleural effusion, the distinction between transudation and exudates was done according to Light's criteria. Exudative pleural effusion is one that meets at least one of the criteria of Light.
FEATURES OF PARAPNEUMONIC EFFUSIONS
The transudative is the effusion that meets all three criteria at the same time: 1) to have intercourse protein p/s below 0.5; 2) intercourse lactate dehydrogenase (LDH) p/s below 0.6, and 3) LDH in pleural fluid under 282 U/L, which is the lowest limit in our laboratory.
Then, the exudative pleural effusions according to their evolution and on the basis of pH, glucose and LDH value in the pleural fluid are divided into: -Uncomplicated parapneumonic effusions: pH >7.2, glucose >60 mg/dl, LDH <1000UI/ml; -Complicated parapneumonic effusions: pH <7.2, glucose <60 mg/dl, LDH >/= 1000 UI/ml.
Pleural fluid obtained by thoracentesis was sent for a series of biochemical, cytological, histopathological and microbiological tests in order to determine the nature of the effusion. The following tests of the pleural fluid were performed:
Physical -Colour, turbidity, viscosity. Biochemical-Glucose, Protein, Albumin, Lactate dehydrogenase (LDH), pH-in the biochemical laboratory of the Infectious Diseases Clinic.
Cytological examination of the pleural fluid-at the Institute of Oncology.
Microbiological examination of the pleural fluid-at the Institute for Microbiology and Parasitology.
Special tests-ADA (adenosine deaminase), lyzozyme and culture for ARB (acid-resistant bacilli) and culture for Lewenstain-at the Institute for lung diseases and tuberculosis.
ERS was determined in all three groups of patients at admission in the Clinic. ERS measures the distance through which erythrocytes fall within 1hour in a vertical tube of anticoagulated blood, and is measured in millimetres/hour. The blood is drawn into a vertical tube anticoagulated with sodium citrate. Leukocyte count (WBC) in serum was also determined in the biochemical laboratory of the Infectious Diseases Clinic, by the white blood cell counter (number per microliter).The amount of protein in serum was determined in the same biochemical laboratory with a standard method. C-reactive protein (CRP) in serum and pleural fluid was measured by quantitative methods in the biochemistry laboratory of same clinic with quantitative sandwich enzyme heterogeneous test, the Ektahem Clinical Chemistry test, with an automated biochemical analyser Vitros 250.
Statistical analysis
Statistical analysis was conducted using SPSS 17 for Windows. For the testing of normality in the distribution of the data we used the Kolmogorov-Smirnov and Shapiro-Wilk's W tests. Categorical traits were displayed by absolute and relative representation with quantitative traits mean, SD, median, minimum, maximum, 25-75 percentiles. To compare the three groups of subjects in relation to the variables analyzed we used Kruskal-Wallis ANOVA and Mann-Whitney U test (Z). For the level of significance or importance, we took the value of p <0.05, a significant higher value of p <0.01. Gender structure of patients with parapneumonic effusion comprised 59.57% male and 40.43% female respondents, and their average age was 53.82±17.5 years. Тhe oldest participant was 93 years, and the youngest 18 years. Of all patients, 72.34% were smokers. Exactly 37 (39.36%) of the participants had previous pneumonia and antibiotic before hospitalization received 61 (64.89%) patients Positive epidemiological survey had 34% of respondents. The results are shown in Table 1 .
RESULTS

Demographic characteristic of respondents
Regarding the seasonal distribution of parapneumonic effusions in this group of patients, the majority of cases were in January (17.2%), then in March and December (11.7%) of hospitalized patients with parapneumonic effusion.
Accompanying diseases
Accompanying chronic diseases had 65.96% of the participants. The most common comorbid condition, alcoholism, was registered in 12.77% of patients with parapneumonic effusion, then diabetes mellitus in 10.64% of patients, and chronic heart diseases in 9 (9.57%). A significant number of patients 8 (8.51%) had two or three comorbidities. 
Presence of symptoms
The most common general symptoms in patients with parapneumonic effusion were fever in 91 (96.81%) and fatigue in 89 (94.68%). Out of symptoms that are more specific for parapneumonic effusions patients usually had pleuritic chest pain 68 (72.34%) and dyspnea (65; 69.15%). Weight loss was also an often represented symptom in 68 (72.34%) cases.
Cough was present in 80 (85.1%) patients, most frequently productive with expectoration of purulent sputum in 32 (34.04%) patients. Haemoptysis had 8 (8.51%) patients.
The average value of temperature before hospitalization was 39.11±1.00C, with average duration of temperature (5.62±5.2) days, with the shortest duration of 1 day and a maximum of 35 days. During hospitalization, the average value of temperature was lower 38.69±1.10C, with patients who did not have a temperature, and with the longest duration of 24 days.
Dullness to percussion had 62 (65.96%) patients, with depress type of breathing in 52 (55.32%) of cases. The shortest duration of auscultatory findings was 7 days, the longest 29 days, the average length of findings of auscultation was 15.87±4.7 days. In 50 % of respondents with parapneumonic effusion, auscultatory findings persisted for more than 15 days. With impaired breathing were 52 (55.32%) patients and without 22 (23.4%) patients. Tachypnea or more than 30 breaths per minute was found in 46.81 % of the respondents.
11.7 % of the respondents had registered a change in mental status or alteration of consciousness in terms of somnolence. Тhose patients were admitted in the intensive care unit until stabilization and normalization of the vital parameters. (Table 2) Radiographic finding Alveolar infiltrates were present in 51(54.25%) participants, while mixed (alveointerstitial infiltrate) in 41(41.49%) of them. When it comes to distribution according to extensiveness, diffuse infiltrates were verified in 37 (39.36%) cases, and then segmental in 35 (37.23%), and lobar in 19 (20.21%) of all cases. Sparsely changes in lung were multilocular in only 19.3% of respondents with parapneumonic effusion. Most respondents had unilaterally distribution of changes in the lung, 67 (71.28%), while bilateral infiltrate were observed in 27 (28.72%) respondents. 
Microbiological findings
Positive cultures of pleural punctate by a microbiological examination of the pleural fluid of the majority of patients were present in 14(14.89%) patients, 4 (4.25%) of them were with Peptostreptococcus, than Staphylococcus aureus and MRSA in 3 (3.19%) patients. Streptococcus pneumoniae was isolated in 2 (2.13%) patients. Аll pleural fluid with direct examination of the bacilli under a microscope, with BACTEC method and Lewenstain culture were negative. 
Biochemical characteristics of pleural fluid in patients with parapneumonic effusion
Values of LDH, pH and glucose are important to separate the uncomplicated and complicated parapneumonic effusions and monitor the stage of the disease. The statistical difference with higher values of LDH in CPPE and lower values of pH and glucose in CPPE, unlike UCPPE was expected.
Besides the three classic parameters used for separation of parapneumonic effusions, LDH, glucose and pH, in all patients CRP was also measured in the pleural fluid. Higher values of CRP in pleural punctate had patients with CPPE (p<0.001), with average value of 150.8 ± 65.9 mg/l, unlike UCPPE with average value of 58.1±42.3 mg/l. 
Antibiotic treatment of patients with parapneumonic effusions
According to the recommendations for the treatment of patients with CAP and parapneumonic effusions most patients with complicated parapneumonic effusion were treated with cephalosporin 3rd gen. and clindamycin. In patients who had no good response, we used cephalosporin in combination with vankomycin and metronidazole. А majority of patients with uncomplicated parapneumonic effusion were treated with cephalosporin 3 rd gen combined with a quinolone or macrolide or tetracycline.
Length of hospitalization
There was statistically significant difference in the hospital days between the two groups. Length of hospitalization and hospital treatment in respondents with CPPE lasted 20.75 ± 18 days and in those with UCPPE 15.78 ± 4.3 days. 
DISCUSSION
Parapneumonic effusions occur in 20 to 40% of patients who are hospitalized with pneumonia. [1, 2] This information is correlated with our study where parapneumonic effusion is verified in 23.18 % of patients hospitalized with CAP. In our study, 59.57% were male that correlate with Dzurik's study where out of 130 patients with parapneumonic effusion, 60% were men. [12] The result is correlated with the tests of Ozol and Tsang where greater number of participants were males who had more inclination to develop CPPE. [17, 18] Average age among our respondents was 53.82 ±17.5 years; the oldest was 93 years old and the youngest 18 years. Age correlates with the age of patients in several studies. [12, 19, 20] We mentioned that there are comorbidities as risk factors for the development of complicated parapneumonic effusions especially empyema. Accompanying chronic diseases had 65.96% of the participants. The most common comorbid condition, alcoholism, was registered in 12.77% of patients with parapneumonic effusion, then diabetes mellitus in 10.64 % of patients, and chronic heart diseases in 9 (9.57%). A significant number of patients 8 (8.51%) had two or three comorbidities. A recent Falguera's study [11] analyzed 4715 patients with CAP and 882 (19%) had pleural effusion, of which 261 (30%) had complicated parapneumonic effusion or empyema. In this study with a multivariable analysis, no single baseline patient's characteristics distinguished patients without pleural effusion from those with uncomplicated parapneumonic effusion. However, five independent baseline characteristics could predict the development of complicated parapneumonic effusion or empyema: age < 60 years old, alcoholism, pleural pain, tachycardia and leucocytosis. In the Chalmer's study also realized in 2011, [19] as in our study, alcoholism was the most common comorbidity which was noted in patients with CPPE, than followed by diabetes mellitus. In this study, having more than one comorbidity proved significant in the development of parapneumonic effusion. In an earlier study as the most common comorbidity when it comes to CPPE was reported diabetes mellitus. [5, 8] Perhaps the explanation of alcoholism, as a significant risk factor is the existence of anaerobic infections in these patients, associated with poor dental hygiene and aspiration. Share of associated diseases and age over 60 years, are risk factors for death in patients with empyema of the pleura. [12] CPPE and empyema occur commonly however, in the absence of any identifiable risk factors. [5] The most common general symptoms in patients with parapneumonic effusion in the study conducted were fever in 91 (96.81%) and fatigue in 89 (94.68%). Out of symptoms more specific for parapneumonic effusions patients usually had pleuritic chest pain 68 (72.34%) and dyspnea (65; 69.15%). Unfortunately, the symptoms of pneumonia involving parapneumonic effusion or empyema (i.e. fever, malaise, cough, dyspnea and pleural chest pain) are similar to those of pneumonia without a parapneumonic effusion. [1, 5] The symptoms of a parapneumonic effusion can be either acute or chronic. [1, 5, 8] Anaerobic pulmonary infections frequently have an associated pleural effusion and are characterized by a more chronic course. [1, 5, 21] Similarly, if the patients have a parapneumonic effusion, the clinical picture is similar whether or not the effusion is complicated. [1] Weight loss and anaemia are common with anaerobic infection. [1, 5] In our patients weight loss was also an often represented symptom in 68 (72.34%) cases. Yet, in the said Falguera's study, chest pain is an important predictive factor for the development of complicated parapneumonic effusion. [21] Because of that, symptoms which are disease specific for pleural infection should not be overlooked. [19, 20, 21] Other common symptom is the fever. High temperature that persists in patients with pneumonia suggests that the inflammatory process takes adverse course and is complicating with the development of parapneumonic effusion. [5, 22] We found that during hospitalization, the average value of temperature was lower 38.69±1.10C in patients who did not have high temperature, with the longest duration of it to 24 days. The parapneumonic effusion should be suspected when in the last 48 hours of antibiotic treatment response is still weak or the patient still has fever or when it is determined that here is an increase in the number of leukocytes ( WBC ) and the value of C-reactive protein (CRP). [14] In this study, dullness to percussion was noticed in 62 (65.96%) patients, with depress type of breathing in 52 (55.32%) of cases. The shortest duration of auscultatory findings was 7 days, the longest 29 days, the average length of findings of auscultation was 15.87±4.7 days. In 50% of respondents with parapneumonic effusion, auscultatory findings persisted for more than 15 days. With impaired breathing were 52 (55.32%) patient and completely silent 22 (23.4%) patients. Tachypnea or more than 30 breaths per minute was observed in 46.81% of the respondents. Dullness to percussion with impaired breathing or completely silent breathing clearly indicate that the patient has pneumonia and parapneumonic effusion. [1, 23] Exactly 11.7% of the respondents had registered a change in mental status or alteration of consciousness in terms of somnolence. Tachypnea > 30 breaths per minute and mental alteration are factors that predict severity and are included in the scores that predict mortality and patient require hospitalization in intensive care units (ICU). [19, 21, 24] At hospital admission all patients were subjected to lung X-rays. Alveolar infiltrates were present in 51 (54.25%) participants, while mixed (alveo-interstitial infiltrate) in 41 (41.49%) of them. When it comes to distribution according to extensiveness, diffuse infiltrates were verified in 37 (39.36%) cases, and then segmental in 35 (37.23%), and lobar in 19 (20.21%) of all cases. Bilateral infiltrate was observed in 27 (28.72%) respondents. Hasley et al. associate in there study with 1906 patients with univariate regression analyses the following radiographic characteristics to be significantly associated with 30-day mortality: 1) bilateral pleural effusions; 2) a pleural effusion of moderate or greater size; 3) 2 or more lobes involved with infiltrate; 4) bilateral infiltrate. [2] Аnalysis of the chest with x-ray is important in everyday practice with an opportunity to indicate the severity of the disease and the possible outcome for the patient. [2, 25] When we are discussing radiographic findings we must mention ultrasound findings of the pleura and lung. Localization of pleural effusion was often in the left costophrenic angle (53; 56.38%), than in the right costophrenic angle, 31 (32.98%). Bilateral pleural effusion was noted in 4 (4.25%) patients. In the mentioned study of Hasley, bilateral pleural effusion has been singled out as an independent factor for prediction of mortality in patients with effusion. [2] Complex non-septated was verified in 48 (51.06%) participants, complex septated in 28 (29.78%), and homogeneously echogenic in 18 (19.15%) patients. Patients with complex septated sonographic pattern had a poorer prognosis for a successful outcome, higher ICU admission rate and a higher mortality rate. [25] The value of ultrasound of pleural effusion is well documented. [26, 27] Even small amounts of pleural effusion can be detected. Ultrasound is helpful in determining the nature of pleural opacity, identifying minimal of loculated effusion, and discriminating between subpulmonary and subphrenic effusions. It is portable and position flexible, and some studies give it an advantage over computed tomography (CT) in the management of pleural effusions. [25] Positive cultures of pleural punctate had 14 (31.81%) patients by a microbiological examination of the pleural fluid of the patient with CPPE. In 4 (4.25%) cases, Peptostreptococcus was isolated, than Staphylococcus aureus and MRSA in 3 (3.19%) patients. Streptococcus pneumoniae was isolated in 2 (2.13%) patients. Global studies report higher numbers of positive pleural punctate which is 32-50% of cases. [25, 28, 29] Our finding fit in the percentage of isolates. In CPPE and empyema in which expected positive isolate culture of points usually as agents are reported gram-positive organisam Streptococcus pneumoniae, gram-negative (Haemophylus influenza), anaerobes (Bacteroid melanogenicus, Peptostreptococcus). [29] But more recent studies in outpatient parapneumonic effusions meet increasingly Staphylococcus aureus, Streptococcus milleri, MRSA, Pseudomonas aeruginosa, Klebsiella pneumoniae and Escherichia coli. [21, 25, 28] Therefore, there are changes in antibiotic treatment in CPPE and empyema. [30] The initial antibiotic cover of patients with parapneumonic effusion is generally dictated by treatment guidelines for pneumonia, and is altered according to blood and pleural fluid microbial sensitivities. [8] Empirical anaerobic antibiotic cover is generally advised. [5] Choices in community-acquired complicated parapneumonc effusion/empyema include intravenous amoxicillin with clavulanic acid or a combination of a second generation cephalosporin and metronidazole. [8, 30] Clindamycin monotherapy is an effective for patients with beta lactam allergy. [8, 30] Possible choices include carbapenems, antipseudomonal penicillins, or third or fourth generation cephalosporins with metdonidazole in patients with community-acquired empyema or nosocomial empyema. Vankomycin, linezolid or alternatives may have to be added for suspected or proven meticillin-resistant S. aureus infection. Aminoglicosides demonstrate poor pleural penetration and reduced efficacy in acidic environments and should be avoided. [8, 19, 30] In a recommendation of the Spanish society of pulmonology and thoracic surgery, cephalosporin it recommended though the penetration into the pleural cavity is slow, but concentrations are stable and persistent. [30] The penetration of quinolones is better than that of the penicillin. [30] According to these recommendations there was a summary that in all cases, empiric antibiotic treatment must be started as early as possible and subsequently adjusted in light of the results of cultures. the characteristics of the patients are significant, the microbiological peculiarities of the local geographical area, and the activity of the chosen antibiotic in pleural fluid. [19, 30] In this study, part of patients with uncomplicated parapneumonic effusion, 18 (19.15%), according to the recommendations for the treatment of patients with CAP, were treated with cephalosporin 3rd gen combined with a quinolone or macrolide or tetracycline. Most patients, 28 (29.79%) were treated with cephalosporin 3rd gen. and clindamycin. In patients who had no good response, we used cephalosporin in combination with vankomycin and metronidazole. Some patients were treated according to the microbiological findings.
There was a statistically significant difference between the values of the ERS, WBC and CRP in serum in both groups of patients, with higher values in patients with CPPE. ERS, WBC and CRP as a marker of inflammation strongly suggests that if some clinical symptoms persist for a longer time and there is no effect of antibiotic treatment, the effusion is complicating. [5, 22] Besides the three classic parameters used for separation of parapneumonic effusions, LDH, glucose and pH, CRP was also measured in the pleural fluid of all patients. Higher values of CRP in pleural punctate had patients with CPPE (p<0.001), with average value of 150.8 ± 65.9 mg/l, unlike UCPPE with an average value of 58.1±42.3 mg/l. The determination of CRP in the pleural fluid in some studies proved to be a good marker for discrimination of UCPPE from CPPE, as in the study of Porcel and collaborators. [31] Table 6 presentsd the length of hospitalization in patients with UCPPE and CPP . With an average length of 21 days, in participants with CPPE, it significantly differs from the length of the hospitalization in participants with UCPPE, with an average length of hospital treatment of 15 days. This leads to additional costs in the treatment of patients and the use of additional healing techniques with increased morbidity and mortality in patients. [8, 12, 19, 21, 30] According to Light's, the classification of parapneumonic effusions with treatment scheme [15] in 8 patients were drained at the Thoraco-cardiovascular Surgery Clinic. In 10 patients, with feature of pleural fluid in addition to just complicated parapneumonic effusions, therapeutic thoracentesis was performed at the Clinic for Infectious Diseases. Limitation of the study is that we did not have the opportunity to use fibrinolytic therapy and to present the results of that kind of treatment.
CONCLUSION
Patients with parapneumonic effusions have symptoms of acute respiratory infection and frequent accompanying diseases. High temperature that persists in patients with pneumonia, and elevated WBC and CRP suggests that the inflammatory process takes adverse course and is complicating. The characteristics of lung radiography, ultrasonography and analysis of pleural fluid further determine the diagnostic and therapeutic treatment. In today's era of broad-spectrum antibiotics and modern imaging techniques, parapneumonic effusions still present a problem with a multitude of unresolved dilemmas.
